Next Article in Journal
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
Next Article in Special Issue
Exploring the Synergy between PARP and CHK1 Inhibition in Matched BRCA2 Mutant and Corrected Cells
Previous Article in Journal
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Previous Article in Special Issue
ATM-Deficient Cancers Provide New Opportunities for Precision Oncology
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Review

Article Versions Notes

Cancers 2020, 12(3), 739; https://doi.org/10.3390/cancers12030739
Action Date Notes Link
article html file updated 31 August 2025 15:01 CEST Update https://www.mdpi.com/2072-6694/12/3/739/html
article html file updated 20 July 2022 23:31 CEST Update -
article html file updated 2 April 2020 06:36 CEST Update -
article html file updated 20 March 2020 14:20 CET Original file -
article pdf uploaded. 20 March 2020 14:18 CET Version of Record https://www.mdpi.com/2072-6694/12/3/739/pdf
article xml uploaded. 20 March 2020 14:18 CET Update https://www.mdpi.com/2072-6694/12/3/739/xml
article xml file uploaded 20 March 2020 14:18 CET Original file -
Back to TopTop